Affiliations 

  • 1 Department of Psychiatry, University of Melbourne, Australia. Electronic address: ieverall@unimelb.edu.au
  • 2 Department of Psychological Medicine, Tan Tock Seng Hospital, Singapore
  • 3 Infectious Diseases Unit, Hospital Pulau Pinang, Penang, Malaysia
  • 4 Department of Consultation-Liaison Psychiatry, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
  • 5 Department of Psychiatry, Infectious Diseases Section, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan
  • 6 Department of Psychiatry, Institute of Behavioural Science in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
  • 7 Division of Infectious Diseases, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
  • 8 Infectious Diseases Department, Tawam Hospital, Al Ain, United Arab Emirates
  • 9 HIV Neurobehavioural Research Centre, Division of Infectious Disease, University of California, San Diego, USA
  • 10 Department of Medicine and Infectious Diseases, Queen Elizabeth Hospital, Hong Kong
  • 11 Department of Preventive and Social Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • 12 Psychiatry and Behavioural Sciences and Internal Medicine, Johns Hopkins University, School of Medicine, Baltimore, USA
  • 13 Department of Psychiatry, Taipei Veteran's General Hospital, Taipei, Taiwan
  • 14 Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Affiliate National Yang Ming University, College of Medicine, Taipei, Taiwan
Asian J Psychiatr, 2016 Aug;22:182-9.
PMID: 26617385 DOI: 10.1016/j.ajp.2015.10.009

Abstract

HIV-associated neurocognitive disorder incurs a significant burden on HIV patients in Asia-Pacific countries; however, the incidence is difficult to estimate due to a lack of local epidemiological data. The impact of neurocognitive impairment in HIV patients is often underestimated due to a lack of education and awareness, and there are consequently gaps in the provision of screening and diagnosis to enable earlier intervention to limit neurocognitive impairment.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.